In reality, the surge of interest in medications like Ozempic and Mounjaro has highlighted something Ive seen for years in my private nutritional therapy practice: for many, the struggle with binge eating and emotional eating is deeply physiological, yet has an element of imbalance in hunger and fullness signals
There is also a class-related warning about thyroid tumors (common to all GLP-1s) based on animal studies, though no such cases were reported in retatrutide trials so far
147 Notably, viral clearance of HCV infection may increase the risk of cardiovascular events
This highlights the need to balance the benefits and disadvantages of such use and to regularly reassess the need for continued proton pump inhibitor treatment. The research was published in The British Medical Journal (BMJ)
Interestingly enough, patients with higher baseline ASCVD risk with tirzepatide therapy showed significantly more reductions in risk [3]
Dose Escalation, Side Effects, and Monitoring Dose escalation is a major part of how incretin-based medicines are studied and used